Woman reading in MDC library

Veröffentlichungen

48 Ergebnisse:
Active Filter:
Sortieren:
in JAMA Oncol

Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial

  • P.J. Bröckelmann
  • H. Goergen
  • U. Keller
  • J. Meissner
  • R. Ordemann
  • T.V. Halbsguth
  • S. Sasse
  • M. Sökler
  • A. Kerkhoff
  • S. Mathas
  • A. Hüttmann
  • M. Bormann
  • A. Zimmermann
  • J. Mettler
  • M. Fuchs
  • B. von Tresckow
  • C. Baues
  • A. Rosenwald
  • W. Klapper
  • C. Kobe
  • P. Borchmann
  • A. Engert
in Leukemia

Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma

  • B. Edginton-White
  • P. Cauchy
  • S.A. Assi
  • S. Hartmann
  • A.G. Riggs
  • S. Mathas
  • P.N. Cockerill
  • C. Bonifer
in Blood

Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma

  • L. von Hoff
  • E. Kärgel
  • V. Franke
  • E. McShane
  • K.W. Schulz-Beiss
  • G. Patone
  • N. Schleussner
  • M. Kolesnichenko
  • N. Hübner
  • O. Daumke
  • M. Selbach
  • A. Akalin
  • S. Mathas
  • C. Scheidereit
in Leukemia

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma

  • N. Schleussner
  • O. Merkel
  • M. Costanza
  • H.C. Liang
  • F. Hummel
  • C. Romagnani
  • P. Durek
  • I. Anagnostopoulos
  • M. Hummel
  • K. Jöhrens
  • A. Niedobitek
  • P.R. Griffin
  • R. Piva
  • H.L. Sczakiel
  • W. Woessmann
  • C. Damm-Welk
  • C. Hinze
  • D. Stoiber
  • B. Gillissen
  • S.D. Turner
  • E. Kaergel
  • L. von Hoff
  • M. Grau
  • G. Lenz
  • B. Dörken
  • C. Scheidereit
  • L. Kenner
  • M. Janz
  • S. Mathas
in Lancet Oncol

Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group

  • D.A. Eichenauer
  • A. Plütschow
  • S. Kreissl
  • M. Sökler
  • J.C. Hellmuth
  • J. Meissner
  • S. Mathas
  • M.S. Topp
  • K. Behringer
  • W. Klapper
  • G. Kuhnert
  • M. Dietlein
  • C. Kobe
  • M. Fuchs
  • V. Diehl
  • A. Engert
  • P. Borchmann
in Leukemia

Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma

  • K.D. Wurster
  • F. Hummel
  • J. Richter
  • M. Giefing
  • S. Hartmann
  • M.L. Hansmann
  • S. Kreher
  • K. Köchert
  • D. Krappmann
  • W. Klapper
  • M. Hummel
  • S.S. Wenzel
  • G. Lenz
  • M. Janz
  • B. Dörken
  • R. Siebert
  • S. Mathas
in Blood

Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin's lymphoma

  • J. Du
  • M. Neuenschwander
  • Y. Yu
  • J.H.M. Däbritz
  • N.R. Neuendorff
  • K. Schleich
  • A. Bittner
  • M. Milanovic
  • G. Beuster
  • S. Radetzki
  • E. Specker
  • M. Reimann
  • F. Rosenbauer
  • S. Mathas
  • P. Lohneis
  • M. Hummel
  • B. Dörken
  • J.P. von Kries
  • S. Lee
  • C.A. Schmitt
in Semin Hematol

Hodgkin lymphoma: pathology and biology

  • S. Mathas
  • S. Hartmann
  • R. Küppers
in Genome Med

A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses

  • K.A.P. de Oliveira
  • E. Kaergel
  • M. Heinig
  • J.F. Fontaine
  • G. Patone
  • E.M. Muro
  • S. Mathas
  • M. Hummel
  • M.A. Andrade-Navarro
  • N. Hübner
  • C. Scheidereit
in Front Biosci

The origins of ALK translocations

  • V. Roukos
  • S. Mathas